Boothbay Fund Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Boothbay Fund Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-202,553	Closed	-$2.08M	–	2600
2023 Q1	$2.08M	Buy	+202,553	New	+$2.06M	0.04%	644

Boothbay Fund Management's ORIA Position: Q2 2023 in Review

Boothbay Fund Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 202,553 shares — an estimated $2.08M sold.

Boothbay Fund Management first reported a position in ORIA in Q1 2023 and held it in 1 quarter. The position peaked at $2.08M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Boothbay Fund Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 202,553 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $2.08M.
Boothbay Fund Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2023 and held it in 1 quarter.
Boothbay Fund Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $2.08M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.